Skip to main content

Showing 1–3 of 3 results for author: Vanderbilt, C M

Searching in archive cs. Search in all archives.
.
  1. arXiv:2208.04910  [pdf

    cs.CV

    Deep Learning-Based Objective and Reproducible Osteosarcoma Chemotherapy Response Assessment and Outcome Prediction

    Authors: David Joon Ho, Narasimhan P. Agaram, Marc-Henri Jean, Stephanie D. Suser, Cynthia Chu, Chad M. Vanderbilt, Paul A. Meyers, Leonard H. Wexler, John H. Healey, Thomas J. Fuchs, Meera R. Hameed

    Abstract: Osteosarcoma is the most common primary bone cancer whose standard treatment includes pre-operative chemotherapy followed by resection. Chemotherapy response is used for predicting prognosis and further management of patients. Necrosis is routinely assessed post-chemotherapy from histology slides on resection specimens where necrosis ratio is defined as the ratio of necrotic tumor to overall tumor… ▽ More

    Submitted 9 August, 2022; originally announced August 2022.

  2. arXiv:2203.15015  [pdf, other

    eess.IV cs.CV

    Deep Interactive Learning-based ovarian cancer segmentation of H&E-stained whole slide images to study morphological patterns of BRCA mutation

    Authors: David Joon Ho, M. Herman Chui, Chad M. Vanderbilt, Jiwon Jung, Mark E. Robson, Chan-Sik Park, ** Roh, Thomas J. Fuchs

    Abstract: Deep learning has been widely used to analyze digitized hematoxylin and eosin (H&E)-stained histopathology whole slide images. Automated cancer segmentation using deep learning can be used to diagnose malignancy and to find novel morphological patterns to predict molecular subtypes. To train pixel-wise cancer segmentation models, manual annotation from pathologists is generally a bottleneck due to… ▽ More

    Submitted 28 March, 2022; originally announced March 2022.

  3. arXiv:2007.01383  [pdf, other

    eess.IV cs.CV q-bio.QM

    Deep Interactive Learning: An Efficient Labeling Approach for Deep Learning-Based Osteosarcoma Treatment Response Assessment

    Authors: David Joon Ho, Narasimhan P. Agaram, Peter J. Schueffler, Chad M. Vanderbilt, Marc-Henri Jean, Meera R. Hameed, Thomas J. Fuchs

    Abstract: Osteosarcoma is the most common malignant primary bone tumor. Standard treatment includes pre-operative chemotherapy followed by surgical resection. The response to treatment as measured by ratio of necrotic tumor area to overall tumor area is a known prognostic factor for overall survival. This assessment is currently done manually by pathologists by looking at glass slides under the microscope w… ▽ More

    Submitted 2 July, 2020; originally announced July 2020.

    Comments: Accepted at MICCAI 2020